Cart
sales@molnova.com
GSK3β inhibitor II
CAS No. 478482-75-6
GSK3β inhibitor II( —— )
Catalog No. M33773 CAS No. 478482-75-6
GSK3β inhibitor II is a GSK3β inhibitor. GSK3β inhibitor II exhibits the research potential of Alzheimer's disease (AD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | Get Quote |
|
| 10MG | 71 | Get Quote |
|
| 25MG | 147 | Get Quote |
|
| 50MG | 251 | Get Quote |
|
| 100MG | 334 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK3β inhibitor II
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK3β inhibitor II is a GSK3β inhibitor. GSK3β inhibitor II exhibits the research potential of Alzheimer's disease (AD).
-
DescriptionGSK3β inhibitor II is an inhibitor ofGSK3β. GSK3β inhibitor II can be used for research of Alzheimer’s disease (AD).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number478482-75-6
-
Formula Weight395.22
-
Molecular FormulaC14H10IN3OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (126.51 mM; Ultrasonic (<60°C)
-
SMILESIc1cccc(CSc2nnc(o2)-c2ccncc2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Elangovan ND, et al. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. J Biomol Struct Dyn. 2021 Nov;39(18):7065-7079. ?
molnova catalog
related products
-
BRD0705
BRD0705 (BRD-0705) is a potent, paralog-selective GSK3α inhibitor with IC50 of 66 nM.
-
CDK8-IN-12
CDK8-IN-12 is a selective, potent and orally active inhibitor of CDK8 (Ki: 14 nM) and is an anti-cancer agent.
-
MBM-55
MBM-55 is an effective inhibitor of NIMA related kinase 2 (NEK2) with an IC50 of 1 nM. MBM-55 effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis.
